244 related articles for article (PubMed ID: 17504997)
21. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
23. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic selection of functional dendritic cells from human lymph nodes.
Boor PP; Ijzermans JN; van der Molen RG; Binda R; Mancham S; Metselaar HJ; Kusters JG; de Jong E; Drexhage HA; Kwekkeboom J
Immunol Lett; 2005 Jul; 99(2):162-8. PubMed ID: 16009266
[TBL] [Abstract][Full Text] [Related]
26. Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.
Molenkamp BG; Vuylsteke RJ; van Leeuwen PA; Meijer S; Vos W; Wijnands PG; Scheper RJ; de Gruijl TD
Am J Pathol; 2005 Nov; 167(5):1301-7. PubMed ID: 16251414
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Lee JH; Torisu-Itakara H; Cochran AJ; Kadison A; Huynh Y; Morton DL; Essner R
Clin Cancer Res; 2005 Jan; 11(1):107-12. PubMed ID: 15671534
[TBL] [Abstract][Full Text] [Related]
28. Regional recurrence after negative sentinel lymph node biopsy for melanoma.
Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
Ann Surg; 2008 Sep; 248(3):378-86. PubMed ID: 18791358
[TBL] [Abstract][Full Text] [Related]
29. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Elliott B; Scolyer RA; Suciu S; Lebecque S; Rimoldi D; Gugerli O; Musat E; Sharma RN; Lienard D; Keilholz U; Testori A; Eggermont A; MacKie R; Robert C; Cook M; Thompson JF; Angevin E; Spatz A;
Clin Cancer Res; 2007 Jul; 13(13):3825-30. PubMed ID: 17606713
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.
Doeden K; Ma Z; Narasimhan B; Swetter SM; Detmar M; Dadras SS
J Cutan Pathol; 2009 Jul; 36(7):772-80. PubMed ID: 19032379
[TBL] [Abstract][Full Text] [Related]
31. Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Germeraad WT; Kishida T; Ueda E; Takenaka H; Mazda O; Kishimoto S
J Dermatol Sci; 2009 Jan; 53(1):40-7. PubMed ID: 18804963
[TBL] [Abstract][Full Text] [Related]
32. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
33. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.
Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V
Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378
[TBL] [Abstract][Full Text] [Related]
34. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
35. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
[TBL] [Abstract][Full Text] [Related]
36. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
[TBL] [Abstract][Full Text] [Related]
37. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
38. Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation.
Constabel H; Stankov MV; Hartwig C; Tschernig T; Behrens GM
J Immunol; 2009 Sep; 183(5):3443-53. PubMed ID: 19667097
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Pashenkov M; Goëss G; Wagner C; Hörmann M; Jandl T; Moser A; Britten CM; Smolle J; Koller S; Mauch C; Tantcheva-Poor I; Grabbe S; Loquai C; Esser S; Franckson T; Schneeberger A; Haarmann C; Krieg AM; Stingl G; Wagner SN
J Clin Oncol; 2006 Dec; 24(36):5716-24. PubMed ID: 17179105
[TBL] [Abstract][Full Text] [Related]
40. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
